Objectives Previous reports on the effects of continuous positive airway pressure (CPAP)
therapy for obstructive sleep apnoea (OSA) on blood pressure has shown contradictory …

Objective: To measure the effects of 4 weeks of nasal positive airway pressure therapy
(PAP) on exercise performance in obstructive sleep apnea patients (OSA). Background …

Continuous positive airway pressure (CPAP) reduces blood pressure levels in hypertensive
patients with obstructive sleep apnoea (OSA). However, the role of CPAP in blood pressure …

Continuous positive airway pressure (CPAP) reduces blood pressure in obstructive sleep
apnoea (OSA) patients, as well as in patients with resistant hypertension. The effect of CPAP …

Objective The effectiveness of continuous positive airway pressure (CPAP) therapy greatly
depends on consistent use. However, data regarding adherence in non-sleepy obstructive …

A common clinical dilemma faced by sleep physicians is in deciding the level of severity at
which patients with obstructive sleep apnea (OSA) should be treated. There is particular …

The treatment of choice for obstructive sleep apnoea (OSA) is continuous positive airway
pressure therapy (CPAP). Since its introduction in clinical practice, CPAP has been used in …

Background Nasal continuous positive airway pressure (NCPAP) is widely used as a
treatment for obstructive sleep apnoea. However, to date there are no randomised controlled …

Pulmonary hypertension has been recognized as being associated with obstructive sleep
apnoea (OSA). Continuous positive airway pressure (CPAP) might reduce pulmonary artery …

Background Continuous positive airway pressure (CPAP) for symptomatic obstructive sleep
apnoea (OSA) improves sleepiness and reduces vascular risk, but such treatment for the …